OpenURL Connection Search

Select item for more details and to access through your institution.

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial.
Published in:
2021
By:
- Kudrow, David;
- Cady, Roger K.;
- Allan, Brent;
- Pederson, Susan M.;
- Hirman, Joe;
- Mehta, Lahar R.;
- Schaeffler, Barbara A.
Publication type:
journal article
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Published in:
Multiple Sclerosis Journal, 2016, v. 22, n. 2, p. 212, doi. 10.1177/1352458515581436
By:
- Hupperts, Raymond;
- Lycke, Jan;
- Short, Christine;
- Gasperini, Claudio;
- McNeill, Manjit;
- Medori, Rossella;
- Tofil-Kaluza, Agata;
- Hovenden, Maria;
- Mehta, Lahar R.;
- Elkins, Jacob
Publication type:
Article
Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Published in:
Multiple Sclerosis Journal, 2014, v. 20, n. 4, p. 464, doi. 10.1177/1352458513502113
By:
- Havrdova, Eva;
- Giovannoni, Gavin;
- Stefoski, Dusan;
- Forster, Samantha;
- Umans, Kimberly;
- Mehta, Lahar;
- Greenberg, Steven;
- Elkins, Jacob
Publication type:
Article
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.
Published in:
Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-021-01376-7
By:
- McAllister, Peter;
- Winner, Paul K.;
- Ailani, Jessica;
- Buse, Dawn C.;
- Lipton, Richard B.;
- Chakhava, George;
- Josiassen, Mette Krog;
- Lindsten, Annika;
- Mehta, Lahar;
- Ettrup, Anders;
- Cady, Roger
Publication type:
Article
Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis.
Published in:
Journal of Neurology, 2014, v. 261, n. 2, p. 316, doi. 10.1007/s00415-013-7196-4
By:
- Giovannoni, Gavin;
- Radue, Ernst-Wilhelm;
- Havrdova, Eva;
- Riester, Katherine;
- Greenberg, Steven;
- Mehta, Lahar;
- Elkins, Jacob
Publication type:
Article
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
Published in:
2021
By:
- Winner, Paul K.;
- McAllister, Peter;
- Chakhava, George;
- Ailani, Jessica;
- Ettrup, Anders;
- Krog Josiassen, Mette;
- Lindsten, Annika;
- Mehta, Lahar;
- Cady, Roger
Publication type:
journal article
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache.
Published in:
Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1421, doi. 10.1111/head.14206
By:
- Marmura, Michael J.;
- Diener, Hans‐Christoph;
- Cowan, Robert P.;
- Tepper, Stewart J.;
- Diamond, Merle L.;
- Starling, Amaal J.;
- Hirman, Joe;
- Mehta, Lahar;
- Brevig, Thomas;
- Cady, Roger
Publication type:
Article
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2.
Published in:
Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 1, p. 125, doi. 10.1111/head.14036
By:
- Diener, Hans‐Christoph;
- Marmura, Michael J.;
- Tepper, Stewart J.;
- Cowan, Robert;
- Starling, Amaal J.;
- Diamond, Merle L.;
- Hirman, Joe;
- Mehta, Lahar;
- Brevig, Thomas;
- Sperling, Bjørn;
- Cady, Roger
Publication type:
Article
Immune Response to Seasonal Influenza Vaccine in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Long-term Daclizumab Beta: A Prospective, Open-Label, Single-Arm Study.
Published in:
International Journal of MS Care, 2017, v. 19, n. 3, p. 141, doi. 10.7224/1537-2073.2016-026
By:
- Mehta, Lahar;
- Umans, Kimberly;
- Ozen, Gulden;
- Robinson, Randy R.;
- Elkins, Jacob
Publication type:
Article
A randomized trial of memantine as treatment for spasticity in multiple sclerosis.
Published in:
Multiple Sclerosis (13524585), 2010, v. 16, n. 2, p. 248, doi. 10.1177/1352458509355462
By:
- Mehta, Lahar R.;
- McDermott, Michael P.;
- Goodman, Andrew D.;
- Schwid, Steven R.
Publication type:
Article
Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
Published in:
Multiple Sclerosis (13524585), 2008, v. 14, n. 3, p. 425, doi. 10.1177/1352458507084107
By:
- Mehta, Lahar R.;
- Samuelsson, Melissa K.;
- Kleiner, Anatole K.;
- Goodman, Andrew D.;
- Anolik, Jennifer H.;
- Looney, R. John;
- Schwid, Steven R.
Publication type:
Article
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
Published in:
2021
By:
- Smith, Timothy R.;
- Spierings, Egilius L. H.;
- Cady, Roger;
- Hirman, Joe;
- Schaeffler, Barbara;
- Shen, Vivienne;
- Sperling, Bjørn;
- Brevig, Thomas;
- Josiassen, Mette Krog;
- Brunner, Elizabeth;
- Honeywell, Loan;
- Mehta, Lahar
Publication type:
Correction Notice
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
Published in:
Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01227-5
By:
- Smith, Timothy R.;
- Spierings, Egilius L. H.;
- Cady, Roger;
- Hirman, Joe;
- Schaeffler, Barbara;
- Shen, Vivienne;
- Sperling, Bjørn;
- Brevig, Thomas;
- Josiassen, Mette Krog;
- Brunner, Elizabeth;
- Honeywell, Loan;
- Mehta, Lahar
Publication type:
Article
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
Published in:
Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01227-5
By:
- Smith, Timothy R.;
- Spierings, Egilius L. H.;
- Cady, Roger;
- Hirman, Joe;
- Schaeffler, Barbara;
- Shen, Vivienne;
- Sperling, Bjørn;
- Brevig, Thomas;
- Josiassen, Mette Krog;
- Brunner, Elizabeth;
- Honeywell, Loan;
- Mehta, Lahar
Publication type:
Article

Found: 14